Suppr超能文献

HIV-1共受体CCR5杂合缺陷与趋化因子产生

Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.

作者信息

Yang J Y, Togni M, Widmer U

机构信息

Division of Clinical Immunology, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland.

出版信息

Cytokine. 1999 Jan;11(1):1-7. doi: 10.1006/cyto.1998.0396.

Abstract

CC chemokine receptor 5 (CCR5) is a cell entry cofactor for macrophage-tropic isolates of human immunodeficiency virus 1 (HIV-1). An inactive CCR5 allele with a 32-nucleotide deletion (CCR5Delta32) has been described that confers resistance to HIV-1 infection in homozygotes and slows the rate of progression to AIDS in heterozygotes. We found the allele CCR5Delta32 to be not rare in 399 Swiss blood donors with a frequency of 0.080. To assess the influence of defective CCR5 on production of its ligands we determined the capacity to produce the chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES in comparison with the production of the CXC chemokine IL-8 which does not bind to CCR5. Production of chemokines was determined during endotoxin stimulation of whole-blood samples ex vivo. Both, basal and LPS-induced chemokine production in 32 blood donors heterozygous for CCR5Delta32 were not significantly different when compared with 55 blood donors who were homozygous for the wild type CCR5 allele.

摘要

CC趋化因子受体5(CCR5)是人类免疫缺陷病毒1型(HIV-1)嗜巨噬细胞分离株进入细胞的辅助因子。已发现一种无活性的CCR5等位基因,其有32个核苷酸的缺失(CCR5Δ32),该等位基因使纯合子对HIV-1感染具有抗性,并减缓杂合子发展为艾滋病的速度。我们发现CCR5Δ32等位基因在399名瑞士献血者中并不罕见,频率为0.080。为了评估缺陷型CCR5对其配体产生的影响,我们测定了与不与CCR5结合的CXC趋化因子白细胞介素-8(IL-8)的产生相比,产生趋化因子巨噬细胞炎性蛋白(MIP)-1α、MIP-1β和调节激活正常T细胞表达和分泌因子(RANTES)的能力。趋化因子的产生是在体外对内毒素刺激的全血样本进行测定的。与55名野生型CCR5等位基因纯合的献血者相比,32名CCR5Δ32杂合的献血者的基础趋化因子产生和脂多糖(LPS)诱导的趋化因子产生均无显著差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验